Revvity Inc. logo

Revvity Inc. (RVTY)

Market Open
5 Dec, 18:00
NYSE NYSE
$
101. 70
-0.85
-0.83%
$
12.39B Market Cap
- P/E Ratio
0.28% Div Yield
13,801 Volume
- Eps
$ 102.55
Previous Close
Day Range
101.12 103.49
Year Range
81.36 128.29
Want to track RVTY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 52 days

Summary

RVTY trading today lower at $101.7, a decrease of 0.83% from yesterday's close, completing a monthly decrease of -1.55% or $1.61. Over the past 12 months, RVTY stock lost -9.54%.
RVTY pays dividends to its shareholders, with the most recent payment made on Nov 07, 2025. The next announced payment will be in In 2 months on Feb 06, 2026 for a total of $0.07.
The last earnings report, released on Nov 03, 2025, missed the consensus estimates by -1.14%. On average, the company has fell short of earnings expectations by -0.4%, based on the last three reports. The next scheduled earnings report is due on Jan 26, 2026.
Revvity Inc. has completed 4 stock splits, with the recent split occurring on Jun 04, 2001.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

RVTY Chart

Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seekingalpha | 3 days ago
Revvity (RVTY) Up 9.5% Since Last Earnings Report: Can It Continue?

Revvity (RVTY) Up 9.5% Since Last Earnings Report: Can It Continue?

Revvity (RVTY) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 week ago
Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript

Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript

Revvity, Inc. ( RVTY ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:00 AM EST Company Participants Maxwell Krakowiak - Senior VP & CFO Prahlad Singh - CEO, President & Director Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division Okay. Thank you.

Seekingalpha | 2 weeks ago

Revvity Inc. (RVTY) FAQ

What is the stock price today?

The current price is $101.70.

On which exchange is it traded?

Revvity Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is RVTY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.28%.

What is its market cap?

As of today, the market cap is 12.39B.

What is the earnings per share?

The EPS is 1.55.

When is the next earnings date?

The next earnings report will release on Jan 26, 2026.

Has Revvity Inc. ever had a stock split?

Revvity Inc. had 4 splits and the recent split was on Jun 04, 2001.

Revvity Inc. Profile

- Industry
- Sector
Prahlad R. Singh CEO
NYSE Exchange
714046109 CUSIP
US Country
11,000 Employees
16 Jan 2026 Last Dividend
4 Jun 2001 Last Split
- IPO Date

Overview

Revvity, Inc., previously known as PerkinElmer, Inc., marks a significant name in the health sciences industry, offering comprehensive solutions, technologies, and services across the globe, including the Americas, Europe, Asia, and other international territories. With its inception in 1937 and headquarters in Waltham, Massachusetts, Revvity has grown to serve an expansive range of clients, including pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. Operating through two main segments - Life Sciences and Diagnostics - Revvity, Inc. brings forward a suite of instruments, reagents, informatics, software, and much more, catering to a wide array of testing, screening, and research needs in the health sciences sector.

Products and Services

Revvity, Inc.'s product portfolio and services are vast, covering various needs within the life sciences and diagnostics fields. Here's an overview of their most notable offerings:

  • AutoDELFIA, BACS-on-Beads, BIOCHIPs, and similar products: These are used for the testing and screening of genetic abnormalities, disorders, and diseases. They serve a critical role in early detection and screening processes for conditions such as down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
  • chemagic, Chitas, DELFIA, DELFIA Xpress, and related instruments: These instruments and technologies are essential for genomic workflows, supporting applications in oncology, immunodiagnostics, drug discovery, and more. They provide the necessary tools for researchers and healthcare practitioners to analyze and understand genetic material and protein interactions.
  • JANUS, LabChip, LifeCycle, LimsLink, and similar software and systems: Key in informatics and laboratory management, these software solutions and systems optimize the operations within laboratories, improving efficiency, data management, and processing in research and diagnostic settings.
  • Migele, MultiPROBE, NEXTFLEX, NextPrep, and other reagents and assay platforms: These products are designed for specific applications within the fields of diagnostics and life sciences research, including DNA sequencing, protein analysis, and more. They are integral to the processes of detecting, analyzing, and understanding complex biological materials.
  • T-SPOT, Twister, VariSpec, ViaCord, VICTOR 2D, Zephyr, and more brand names: Under these brand names, Revvity, Inc. offers a diverse range of products that cater to different aspects of health sciences, from diagnostic tests for infectious diseases to advanced instruments for genetic and proteomic research. Each brand specializes in a unique area of the health sciences, providing specialized tools and technologies to their respective fields.

Contact Information

Address: 940 Winter Street
Phone: 781 663 6900